IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
about
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic PerspectivesPreliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder CancerInactivation of the transcription factor GLI1 accelerates pancreatic cancer progression.Thrombomodulin expression regulates tumorigenesis in bladder cancerIL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.Impact of CD44 expression on radiation response for bladder cancerReduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancerIncreased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer.Influences of laparoscopic-assisted gastrectomy and open gastrectomy on serum interleukin-6 levels in patients with gastric cancer among Asian populations: a systematic reviewFibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.Immunological basis in the pathogenesis and treatment of bladder cancerCancer prevention and therapy through the modulation of the tumor microenvironment.Regulation of SLD5 gene expression by miR-370 during acute growth of cancer cellsExpression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer.Chronic inflammation in urothelial bladder cancer.Role of interleukin-6 in cancer progression and therapeutic resistance.Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue.Correction: IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer.Development of an interstitial cystitis risk score for bladder permeability.Inflammatory microenvironment in the initiation and progression of bladder cancer.Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.Energy Balance Modulation Impacts Epigenetic Reprogramming, ERα and ERβ Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice.Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.Predictive value of salivary microRNA-320a, vascular endothelial growth factor receptor 2, CRP and IL-6 in Oral lichen planus progression.Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes.Autotaxin upregulated by STAT3 activation contributes to invasion in pancreatic neuroendocrine neoplasms
P2860
Q26771263-A6219964-EF8D-4AD6-8E68-81EC1C794F9FQ28390776-9016AB01-90CA-470A-9405-A235387931ABQ33718581-155A15F1-ABAB-41D1-8774-581107966EACQ33733056-D45BB5EA-5A92-4096-BFCC-891395F3D008Q33772144-0593D50F-4674-437D-8E11-14F18D209FDCQ33776678-A6B61E16-0869-4003-B0E6-BFD31C830417Q33838828-C7FD3409-C0A7-4EF7-AE8D-2505EF1472F2Q35158100-46AFE292-9425-4F67-84CF-9C459A4C3B3DQ35583924-A6DD4EA0-BE73-4EB1-AA60-4F7B5F195E40Q35666458-A41C7999-A474-4761-9BD2-7EF793DA40A4Q36260118-12D641CE-039F-4C1E-93ED-E9C471DA254BQ37058267-254293E9-04C4-486B-9A27-65D99341A541Q37157540-514C694B-6282-47B3-8AC8-0AADBAF6EAEBQ37432292-CD0BCD96-3EE7-4718-A76B-0D7137C51547Q38379205-35D83DAA-433F-4BDF-A7E5-374725714EB9Q38564597-593850EC-87FC-4555-9E51-3C74C63A97E7Q38853625-3D3163B2-6EEA-448D-89E3-F96E4ED00A9FQ39359483-A9C273FA-45C0-4A3B-8103-80C9A80D93C6Q41204113-1C32B803-B81C-40C7-B463-485F564F8C7BQ42785685-4D88B5F2-E88B-425C-8F66-DA461D9B6909Q45948914-46AB5E3F-E4AD-4797-ADEB-FFBA7F2E2AC4Q46779353-B5265AB7-46D3-4EA7-857A-E07D0B481AB4Q47291991-6F849C78-6AB4-4B02-9320-B4115D6D5373Q47805414-21116E53-A222-42B3-B136-4FDFB31C2EABQ49901112-B60BFF55-CFF3-477B-A5B8-D50313450BEAQ51003238-A478C0FC-BBAB-474A-89F5-5B4F1B289571Q55423400-EA63EA06-A1CE-41EF-A34F-2B911AFAA3ECQ57818887-F9EE31DB-0A40-4942-9A0C-006367C5627E
P2860
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@ast
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@en
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@nl
type
label
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@ast
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@en
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@nl
prefLabel
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@ast
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@en
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@nl
P2093
P2860
P1433
P1476
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer
@en
P2093
Ching-Fang Wu
Chun-Te Wu
Miao-Fen Chen
Paul-Yang Lin
Wen-Cheng Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0061901
P407
P577
2013-04-30T00:00:00Z